35602375|t|Management of Psychiatric Disorders in Patients with Endocrine Disorders.
35602375|a|The neuropsychiatric symptoms and disorders among endocrine disorders are discussed in the context of current global and local epidemiological data. Neuropsychiatric symptoms, clinical differentials in hypothyroidism, hyperthyroidism, and parathyroid disorders, and relevant management protocols are described. HPT axis and its interaction with psychotropic usage are mentioned. Stress diathesis, depression, anxiety disorders, and severe mental illnesses and their respective association with diabetes, the relevant mechanisms, and management protocols are stated. The metabolic syndrome, its definition, and its relationship to psychotropic usage are laid out. Moreso, best clinical practices for scenarios such as hyperprolactinemia and psychiatric illnesses, and steroid-induced psychosis are mentioned.
35602375	14	35	Psychiatric Disorders	Disease	MESH:D001523
35602375	39	47	Patients	Species	9606
35602375	53	72	Endocrine Disorders	Disease	MESH:D004700
35602375	78	117	neuropsychiatric symptoms and disorders	Disease	MESH:D001523
35602375	124	143	endocrine disorders	Disease	MESH:D004700
35602375	276	290	hypothyroidism	Disease	MESH:D007037
35602375	292	307	hyperthyroidism	Disease	MESH:D006980
35602375	313	334	parathyroid disorders	Disease	MESH:D010279
35602375	453	459	Stress	Disease	MESH:D000079225
35602375	471	481	depression	Disease	MESH:D003866
35602375	483	500	anxiety disorders	Disease	MESH:D001008
35602375	513	529	mental illnesses	Disease	MESH:D001523
35602375	568	576	diabetes	Disease	MESH:D003920
35602375	644	662	metabolic syndrome	Disease	MESH:D024821
35602375	791	809	hyperprolactinemia	Disease	MESH:D006966
35602375	814	835	psychiatric illnesses	Disease	MESH:D001523
35602375	841	848	steroid	Chemical	MESH:D013256
35602375	857	866	psychosis	Disease	MESH:D011618
35602375	Positive_Correlation	MESH:D013256	MESH:D011618

